CXCR2 Antibody

Shipped with Ice Packs
In Stock

Description

Definition and Mechanism

CXCR2 antibodies are monoclonal antibodies engineered to bind the extracellular N-terminal domain of CXCR2, competing with its natural ligands (e.g., CXCL8/IL-8, CXCL1/GROα) . By blocking receptor activation, these antibodies inhibit downstream signaling pathways, including calcium mobilization and MAPK/PI3K cascades, thereby halting neutrophil chemotaxis and inflammation .

Key Features:

  • Binding Affinity: Picomolar (pM) affinity, surpassing natural ligands (e.g., IL-8 binds at nanomolar concentrations) .

  • Selectivity: Targets CXCR2 exclusively, avoiding cross-reactivity with CXCR1 or other chemokine receptors .

Therapeutic Applications

CXCR2 antibodies have shown efficacy in preclinical models of neutrophil-driven diseases:

Disease ModelKey FindingsSource
Atopic Dermatitis (AD)Rapidly clears inflammation by reducing neutrophil infiltration
Rheumatoid Arthritis (RA)Reduces joint inflammation and tissue damage
Multiple Sclerosis (EAE)Alleviates neuroinflammation and improves motor function
CancerInhibits tumor growth and angiogenesis via CXCR2 blockade

Development and Engineering

The antibody development process leverages combinatorial libraries and epitope-guided selection:

  • Lead Candidate: The optimized antibody (e.g., abN48-2-IgG1) binds CXCR2 with 100-fold higher affinity than earlier variants due to arginine substitutions in complementarity-determining regions (CDRs) .

  • Humanization: TAHX2 and HAHX2 variants were developed for human and murine models, respectively, ensuring cross-species compatibility .

Research Highlights and Challenges

Efficacy:

  • In murine models, CXCR2 antibodies neutralize IL-8-induced chemotaxis (in vitro) and reduce neutrophil counts in inflamed tissues (in vivo) .

  • Anti-CXCR2 therapy outperforms anti-TNF agents by targeting the receptor directly, potentially minimizing off-target effects .

Challenges:

  • Small-molecule inhibitors failed clinically due to poor binding and off-target activity, underscoring the need for antibody-based approaches .

  • Clinical trials are pending to validate human efficacy and safety.

References

  1. Nature (2021): Picomolar antibody targeting CXCR2 N-terminus for neutrophil-related diseases .

  2. PMC (2018): CXCR2’s role in neutrophil migration and inflammatory disorders .

  3. PMC (2020): Therapeutic blockade in AD and RA models .

  4. R&D Systems (2021): Mouse CXCR2 antibody characterization .

  5. Nature (2021): CXCR2 antibody development and EAE studies .

  6. BioLegend (2015): CXCR2 antibody for flow cytometry .

  7. R&D Systems (2021): Human CXCR2 antibody validation .

  8. J. Immunol. (2004): CXCR2 depletion in tumor models .

  9. BD Biosciences (2021): Mouse CXCR2 antibody for research .

Product Specs

Buffer
PBS with 0.02% Sodium Azide, 50% Glycerol, pH 7.3. Store at -20°C. Avoid freeze/thaw cycles.
Lead Time
Typically, we can ship products within 1-3 business days of receiving your order. Delivery times may vary depending on the purchasing method or location. Please consult your local distributor for specific delivery information.
Synonyms
C-X-C chemokine receptor type 2 antibody; CD 182 antibody; CD182 antibody; CD182 antigen antibody; CDw128b antibody; Chemokine (CXC) receptor 2 antibody; CMKAR2 antibody; CXC-R2 antibody; CXCR 2 antibody; CXCR-2 antibody; CXCR2 antibody; CXCR2_HUMAN antibody; GRO/MGSA receptor antibody; High affinity interleukin-8 receptor B antibody; IL 8 receptor type 2 antibody; IL 8R B antibody; IL-8 receptor type 2 antibody; IL-8R B antibody; IL8 RB antibody; IL8 receptor type 2 antibody; IL8R B antibody; IL8R2 antibody; IL8RA antibody; Interleukin 8 Receptor B antibody; Interleukin 8 receptor; beta antibody; Interleukin 8 receptor; type 2 antibody
Target Names
Uniprot No.

Target Background

Function
CXCR2 is a receptor for interleukin-8, a potent neutrophil chemotactic factor. Binding of IL-8 to CXCR2 activates neutrophils, triggering a response mediated by a G-protein that activates a phosphatidylinositol-calcium second messenger system. CXCR2 binds to IL-8 with high affinity and also binds with high affinity to CXCL3, GRO/MGSA, and NAP-2.
Gene References Into Functions
  • The CXCR2 rs1126579 TT genotype was associated with a significantly increased likelihood of spontaneous HCV clearance. PMID: 29948377
  • CXCR2 protein expression was upregulated in both the epileptic foci of temporal lobe epilepsy patients and in the pilocarpine mouse model. Administration of the CXCR2-selective antagonist SB225002 during the latency window preceding spontaneous recurrent seizures (SRSs) onset suppressed SRSs activity during the chronic period of epilepsy. PMID: 28705496
  • Results indicated that the CXCR2 +1208 CT genotype is less frequent in advanced stages of prostate cancer, suggesting that this chemokine receptor plays a role in the pathogenesis of this disease. PMID: 28668699
  • CXCR2 expression promotes both local and distant metastasis of colorectal cancer (CRC) and is associated with unfavorable prognosis for CRC patients. Furthermore, CXCR2 can stratify high-risk patients, particularly in those with normally early stage low-risk CRC. PMID: 28415702
  • PADI4 contributes to gastric tumorigenesis by upregulating CXCR2, KRT14, and TNF-alpha expression. PMID: 27556695
  • KHSV miR-K3 activates the GRK2/CXCR2/AKT axis, inducing KSHV-induced angiogenesis and promoting KSHV latency. PMID: 27058419
  • CXCR2 mRNA and protein expression levels were significantly decreased in preeclamptic placentas compared to normal controls. Silencing CXCR2 significantly inhibited the invasive abilities of two trophoblast cell lines, while CXCR2 overexpression promoted trophoblast cell invasion. PMID: 27324095
  • CXCR2 promotes breast cancer metastasis and chemoresistance by suppressing AKT1 and activating COX2. PMID: 28964785
  • CXCR2 is required for the recruitment of tumor-associated neutrophils (TANs), which in turn suppress antitumor T-cell responses. CXCR2 ligands, particularly CXCL5, are elevated in both human and mouse pancreatic ductal adenocarcinoma (PDA). PMID: 27737879
  • This study demonstrates that neutrophil expression levels of CVCR2 are decreased in septic patients. PMID: 27016001
  • CXCR4 and CXCR2 were highly expressed in a highly invasive gastric cancer cell model and in gastric cancer tissues. Crosstalk between CXCR4 and CXCR2 contributed to epithelial-mesenchymal transition (EMT), migration, and invasion of gastric cancer. PMID: 28481874
  • A unique viral protein, vCXCL1, targets three chemokine receptors: CXCR1 and CXCR2 expressed on neutrophils and CXCR1 and CX3CR1 expressed on Natural killer cells. PMID: 27160907
  • The expressions of CXCL1 in cancer cells and CXCR2 in stromal cells are useful prognostic factors for gastric cancer patients. PMID: 28575019
  • CXCR2 preferentially supports the maintenance of human pluripotent stem cell characteristics as well as facilitates ectodermal differentiation after commitment to differentiation. This mechanism might be associated with mTOR, beta-catenin, and hTERT activities. PMID: 27188501
  • Results showed that CXCR2 expression was correlated with high grade (P = 0.024), advanced stage (P = 0.029), and metastasis (P = 0.018). The log-rank test revealed that high CXCR2 and CXCR3 expressions are related to poorer overall survival (P < 0.001; P < 0.001). PMID: 27273823
  • These data demonstrate that the CXCR2 network and CXCL4 play a role in the maintenance of normal hematopoietic stem cell/hematopoietic progenitor cell (HSC/HPC) cell fates, including survival and self-renewal. PMID: 27222476
  • CXCR1 and CXCR2 regulate hepatocyte exosome release. While the mechanism utilized by CXCR1 remains elusive, CXCR2 appears to modulate neutral sphingomyelinase (Nsm) activity and resultant production of ceramide to control exosome release. CXCR1 is required for packaging of enzymes into exosomes that mediate their hepatocyte proliferative effect. PMID: 27551720
  • TNF-alpha augments CXCR2 and CXCR3 to promote the progression of renal cell carcinoma, leading to a poor prognosis. PMID: 27297979
  • Data indicate that the crystal structure of PDZ-RhoGEF PDZ domain in complex with the CXC chemokine receptor 2 (CXCR2) C-terminal PDZ binding motif. PMID: 28179147
  • Treatment with 1,25D3 increased poly(I:C)-induced IL-8 mRNA and protein expression after 2 to 6 hours. However, when cells were pretreated with 1,25D3 for 24 hours, 1,25D3 decreased cytokine expression. PMID: 27196318
  • Novel pathways associated with GPI-AP- granulocytes were identified using RNA-seq, and higher CXCR2 expression was validated in GPI-AP- than GPI-AP+ granulocytes. PMID: 28151558
  • Results identify the CXCL2/MIF-CXCR2 axis as an important mediator in myeloid-derived suppressor cell (MDSC) recruitment and as predictors in bladder cancer. PMID: 27721403
  • This study demonstrates that CXCR2 signaling in the myeloid compartment is tumor-promoting and required for pancreatic cancer metastasis. PMID: 27265504
  • The usefulness of CXCR-2 as a potential tumor marker of esophageal cancer was investigated. PMID: 27906878
  • This study shows that downregulation of CD182 after stimulation with IL-8 is more pronounced in adults than in neonates, whereas formyl-methionyl-leucyl-phenylalanine (fMLP) induces changes in receptor expression that are of the same magnitude in neutrophils from neonates as from adults. PMID: 27606963
  • Findings present that miR-940 acts as a pivotal adaptor of CXCR2 and its transcription downregulated CXCR2 expression to decrease hepatocellular carcinoma (HCC) invasion and migration in vitro. PMID: 27807540
  • Our findings suggest that CXCL3 and its receptor CXCR2 are overexpressed in prostate cancer cells, prostate epithelial cells, and prostate cancer tissues, which may play multiple roles in prostate cancer progression and metastasis. PMID: 26837773
  • Data suggest that neutrophil-activating peptide 2 (NAP-2) secreted by natural killer (NK) cells can bind to CXC Chemokine Receptor 2 (CXCR2) on mesenchymal stem cells (MSCs) leading to stimulation of its recruitment. PMID: 27052313
  • High CXCR2 expression is associated with pancreatic cancer. PMID: 26771140
  • The results of this study show that the CXCR2 rs1126579 polymorphism is significantly associated with ischemic stroke, both individually and in combination with the genotype and/or alleles of other chemokine genes. PMID: 26648969
  • These studies provide direct evidence linking the activation of IL8, DNA demethylation, and the induction of the osteoarthritis (OA) process with important therapeutic implications for patients with this debilitating disease. PMID: 26521741
  • CXCR2 expression is enriched in human atherosclerotic coronary artery. PMID: 26287498
  • The CXCR2-CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma. PMID: 26503598
  • It was found that the mRNA level of NF-kappaB and IL-8 was higher in gastric ulcer patients, especially in patients with H.pylori-positive gastric ulcer. PMID: 26060478
  • This study shows that CXCL5 expression is elevated in positive correlation to bladder cancer grade and promotes cell migration and invasion via binding to its receptor CXCR2. PMID: 26058729
  • CXCR2 positivity combined with postoperative complications is associated with subsequent tumor recurrence in esophageal cancer. PMID: 26231560
  • IL-10 rs1800896, CXCR2 rs1126579, and selected clinical features can be used as markers for septic shock development but not for decreased survival. PMID: 26038959
  • Changes in promoter methylation patterns were investigated using methylation arrays and it was observed that the promoters of immunomodulatory factors, COX2 and PTGES, and migration-related factors, CXCR2 and CXCR4, were hypomethylated after 5-aza treatment. PMID: 25620445
  • TLR3 stimulates the differentiation of mesenchymal stromal cells from human tonsils into follicular dendritic cell-like cells and induces chemokine secretion, possibly by recruiting C-X-C chemokine receptor 2-expressing immune cells. PMID: 25794662
  • Data show that long non-coding RNA (lncRNA) MALAT1 silencing downregulated the expression of the microRNA miR-22-3p target gene CXCR2 and the AKT pathway. PMID: 26364720
  • Data revealed a critical role of a PDZ-based CXCR2 macromolecular complex in endothelial progenitor cell (EPC) homing and angiogenesis. PMID: 25622052
  • Results demonstrated that resistance to anti-proliferative effects of CXCR2 may also arise from feedback increases in macrophage inflammatory protein-2 (MIP-2) secretion. PMID: 25682075
  • CXCR2 is a potential independent adverse prognostic biomarker for recurrence and survival of patients with non-metastatic clear cell renal cell carcinoma (ccRCC) after nephrectomy. PMID: 26188847
  • Results showed that Helicobacter pylori (H. pylori) induced the activation of Jak1/Stat3 and IL-8 production, which was inhibited by a Jak/Stat3-specific inhibitor AG490 in AGS cells in a dose-dependent manner. PMID: 25837197
  • Data indicate that the antibodies bound specifically to CXC chemokine receptor-2 (CXCR2)-expressing cells. PMID: 25484047
  • Data indicate the antibodies recognized distinct epitopes of CXC chemokine receptor-2 (CXCR2). PMID: 25484064
  • Our results reveal that circulating concentrations of IL-8 and IL-12 increase along with important vascular threatening traits such as fasting serum glucose and very low-density lipoprotein cholesterol (VLDL-c), respectively. PMID: 25456886
  • miR141-CXCL1-CXCR2 signaling-induced regulatory T cell (Treg) recruitment regulates metastases and survival of non-small cell lung cancer. PMID: 25349304
  • A 3' untranslated region (3'UTR) single nucleotide polymorphism (SNP) modulates CXCR2 expression, signaling, and susceptibility to lung cancer. PMID: 25480945
  • Data demonstrate that CXCR2 regulates bone marrow blood vessel repair/regeneration and hematopoietic recovery, and clinically may be a therapeutic target for improving bone marrow transplantation. PMID: 25757087

Show More

Hide All

Database Links

HGNC: 6027

OMIM: 146928

KEGG: hsa:3579

STRING: 9606.ENSP00000319635

UniGene: Hs.846

Protein Families
G-protein coupled receptor 1 family
Subcellular Location
Cell membrane; Multi-pass membrane protein.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.